Skip to content Accessibility statement

Prescription drugs found in York's rivers

News

Posted on Tuesday 12 June 2018

Scientists have detected 29 different pharmaceutical drugs in York’s two rivers – with some levels higher than previously observed across parts of Europe and Asia.


Scientists testing the water.

Samples were taken from the Foss and Ouse and revealed the presence of a range of drug compounds, including antidepressants, antibiotics, antihistamines and medicines to treat epilepsy and diabetes.

The study, one of the most detailed ever undertaken with samples taken from 11 sites over a 12 month period, has raised concerns about the possible environmental impact.

Seasonal spikes

The authors of the study said concentrations of some drugs were higher than previously observed in parts of Europe and Asia.

The results also revealed seasonal spikes, with higher levels of antihistamines in the summer and higher levels of drugs associated with cold and flu symptoms in the winter.

The research team also discovered compounds from drugs not usually available in the UK, but believe they were brought to the city by tourists from the U.S and China and discharged in to the waterways after they were ingested.

The study was led by Emily Burns in the University of York’s Department of Chemistry and overseen by Professor Alistair Boxall from the University of York’s Environment Department.

Exposure

Professor Boxall said: “There isn’t any evidence for impact on human health from pharmaceuticals in rivers, but it definitely deserves more investigation.”

“If you compare the levels found in the study with what a patient takes then the degree of exposure is very low. For example, we saw concentrations of metformin – a drug used to treat type diabetes at around 500 nanograms per litre.

“If you drank two litres of this water, you would get about a millionth of a patient’s daily dose of the drug.

Professor Boxall added: “However, it is important to realise that these drugs are being emitted continuously into the environment and that we will be exposed to them across our lifetime. There is therefore a concern that some may be causing harm.”

“It is a really complex issue to tackle and we don’t really have the methods to understand whether long-term exposure to low levels of pharmaceuticals matters or not.”

Impact

Professor Boxall said the impact on the ecosystem was also a consideration, with previous laboratory-based studies revealing pharmaceuticals can affect the behaviour and reproduction of fish and invertebrates at the types of levels seen in the environment. 

Scientists are now trying to establish whether these effects occur in the real environment.

The study has laid the foundations for a new global project being led by the University of York looking at water samples taken from 60 rivers around the world. The results of which should be known by the end of the year.

The Ouse and Foss results are published in Water Research and the study was funded by the EU’s Seventh Framework Programme.

Research newsletter

Our monthly research newsletter features a curated mix of news, events, and recent discoveries delivered straight to your inbox.

Sign up

Explore more news

News

16 July 2026

The University of York has joined the Defence Universities Alliance (DUA) - a major new national partnership launched by the Ministry of Defence (MOD).

News

14 July 2026

BAFTA-winning actor, Suranne Jones; celebrated broadcaster and economist, Evan Davis; and pioneer of India’s IT industry, NR Narayana Murthy, are among eight distinguished figures to receive honorary degrees from the University of York in July.

News

9 July 2026

Nine out of 10 students at the University of York are satisfied with the academic support they receive, according to the results of the 2026 National Student Survey (NSS).

News

3 July 2026

Bears often get a bad reputation, but a new study shows that they might not be the species most often involved in human-wildlife interaction that can lead to conflicts in national parks.

News

1 July 2026

Predicting whether a company's profits will rise or fall has long been one of the most notoriously difficult tasks in finance. Corporate earnings underpin trillions of dollars in market valuation, yet traditional forecasting models are routinely upended by economic shocks, shifting consumer tastes, and unexpected corporate crises.

Read more news